![Swapnil Jatinbhai Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Swapnil Jatinbhai Shah
Vorstandsvorsitzender bei
SENORES PHARMACEUTICALS LIMITED
Vermögen: 80 Mio $ am 31.07.2026
Profil
Swapnil Jatinbhai Shah is Non-Executive Chairman at Remus Pharmaceuticals Ltd. since 2015.
Holds the position of Managing Director & Executive Director at Senores Pharmaceuticals Ltd. since 2021.
Serves as Director at Ratnagene Lifescience Pvt Ltd., Relius Lifesciences Pvt Ltd., Ratnatris Pharmaceuticals Pvt Ltd., Calypso Hospitality LLP, Sumer Enterprises LLP, Renosen Pharmaceuticals Pvt Ltd., Espee Therapeutics LLP, Aelius Projects LLP, Havix Group, Inc., and Senores Pharmaceuticals, Inc. Education includes an MBA from Hofstra University and undergraduate degrees from Gujarat University and Nirma University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2026 | 5’848’031 ( 12.7% ) | 80 Mio $ | 31.07.2026 |
Aktive Positionen von Swapnil Jatinbhai Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| REMUS PHARMACEUTICALS LIMITED | Vorsitzender | 21.09.2015 |
| SENORES PHARMACEUTICALS LIMITED | Vorstandsvorsitzender | 15.10.2021 |
Relius Lifesciences Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Renosen Pharmaceuticals Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Ratnatris Pharmaceuticals Pvt Ltd.
 Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | Direktor/Vorstandsmitglied | - |
Ratnagene Lifescience Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Espee Therapeutics LLP | Direktor/Vorstandsmitglied | - |
Aelius Projects LLP | Direktor/Vorstandsmitglied | - |
Calypso Hospitality LLP | Direktor/Vorstandsmitglied | - |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Swapnil Jatinbhai Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gujarat University
 Gujarat University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nirma University
 Nirma University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Havix Group, Inc.
 Havix Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Senores Pharmaceuticals Pvt Ltd.
 Senores Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and generic medicines | Health Technology |
Remus Pharmaceuticals Ltd.
 Remus Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products with expertise in neurology, cardiology & gastroenterology | Health Technology |
Senores Pharmaceuticals, Inc.
 Senores Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
Ratnagene Lifescience Pvt Ltd. | |
Relius Lifesciences Pvt Ltd. | |
Ratnatris Pharmaceuticals Pvt Ltd.
Ratnatris Pharmaceuticals Pvt Ltd. Ratnatris Pharmaceuticals Pvt Ltd. is a pharmaceutical company specializing in the development, manufacturing, and supply of affordable, high-quality generic medicines and innovative formulations. Ratnatris operates seven advanced manufacturing facilities, including a US FDA-approved plant in the USA, and produces oral solids, parenterals, beta lactams, and cephalosporins. The company is based in Ahmedabad, India. The Indian company offers a broad portfolio of over 500 commercial products across multiple therapeutic categories, including anaesthetics, anti-infectives, cardiovascular, central nervous system, and nutritional supplements. The company focuses on continuous innovation, developing complex generics supported by robust R&D, clinical trials, regulatory compliance, and intellectual property expertise. Ratnatris maintains stringent quality standards aligned with WHO cGMP and ISO 9001:2008, and holds certifications from various national health authorities. | |
Calypso Hospitality LLP | |
Sumer Enterprises LLP | |
Renosen Pharmaceuticals Pvt Ltd. | |
Espee Therapeutics LLP | |
Aelius Projects LLP |
